Class information for:
Level 2: SYSTEMIC SCLEROSIS//SCLERODERMA//RAYNAUDS PHENOMENON

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1184 8906 30.8 67%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
312 35775 LOW BACK PAIN//SYSTEMIC SCLEROSIS//SCLERODERMA

Classes in level below (level 1)


ID, lev. below Publications Label for level below
2316 2217 SYSTEMIC SCLEROSIS//SCLERODERMA//SCLERODERMA RENAL CRISIS
3412 1914 RAYNAUDS PHENOMENON//CAPILLAROSCOPY//DIGITAL ULCERS
3652 1860 SYSTEMIC SCLEROSIS//SCLERODERMA//TIGHT SKIN MOUSE
10334 1006 PARRY ROMBERG SYNDROME//LOCALIZED SCLERODERMA//MORPHEA
10515 991 EOSINOPHILIA MYALGIA SYNDROME//EOSINOPHILIC FASCIITIS//TOXIC OIL SYNDROME
16423 589 SCLEROMYXEDEMA//PAPULAR MUCINOSIS//LICHEN MYXOEDEMATOSUS
22330 329 SCLERODERMA HEART DISEASE//HEART INVOLVEMENT//SMALL CORONARY ARTERY DISEASE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 SYSTEMIC SCLEROSIS Author keyword 1408 56% 19% 1694
2 SCLERODERMA Author keyword 707 52% 11% 960
3 RAYNAUDS PHENOMENON Author keyword 305 58% 4% 351
4 EOSINOPHILIC FASCIITIS Author keyword 170 83% 1% 95
5 EOSINOPHILIA MYALGIA SYNDROME Author keyword 167 85% 1% 87
6 LOCALIZED SCLERODERMA Author keyword 161 76% 1% 112
7 PARRY ROMBERG SYNDROME Author keyword 137 86% 1% 71
8 MORPHEA Author keyword 130 66% 1% 122
9 SCLEROMYXEDEMA Author keyword 89 81% 1% 54
10 TOXIC OIL SYNDROME Author keyword 71 74% 1% 52

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class		 LCSH search Wikipedia search
1 SYSTEMIC SCLEROSIS 1408 56% 19% 1694 Search SYSTEMIC+SCLEROSIS Search SYSTEMIC+SCLEROSIS
2 SCLERODERMA 707 52% 11% 960 Search SCLERODERMA Search SCLERODERMA
3 RAYNAUDS PHENOMENON 305 58% 4% 351 Search RAYNAUDS+PHENOMENON Search RAYNAUDS+PHENOMENON
4 EOSINOPHILIC FASCIITIS 170 83% 1% 95 Search EOSINOPHILIC+FASCIITIS Search EOSINOPHILIC+FASCIITIS
5 EOSINOPHILIA MYALGIA SYNDROME 167 85% 1% 87 Search EOSINOPHILIA+MYALGIA+SYNDROME Search EOSINOPHILIA+MYALGIA+SYNDROME
6 LOCALIZED SCLERODERMA 161 76% 1% 112 Search LOCALIZED+SCLERODERMA Search LOCALIZED+SCLERODERMA
7 PARRY ROMBERG SYNDROME 137 86% 1% 71 Search PARRY+ROMBERG+SYNDROME Search PARRY+ROMBERG+SYNDROME
8 MORPHEA 130 66% 1% 122 Search MORPHEA Search MORPHEA
9 SCLEROMYXEDEMA 89 81% 1% 54 Search SCLEROMYXEDEMA Search SCLEROMYXEDEMA
10 TOXIC OIL SYNDROME 71 74% 1% 52 Search TOXIC+OIL+SYNDROME Search TOXIC+OIL+SYNDROME

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 SCLERODERMA 1214 47% 22% 1927
2 SYSTEMIC SCLEROSIS 314 27% 11% 992
3 RAYNAUDS PHENOMENON 244 43% 5% 438
4 LINEAR SCLERODERMA 240 89% 1% 110
5 PROGRESSIVE SYSTEMIC SCLEROSIS 213 49% 4% 316
6 LOCALIZED SCLERODERMA 180 53% 3% 239
7 DIFFUSE SCLERODERMA 143 78% 1% 95
8 LICHEN MYXEDEMATOSUS 134 82% 1% 78
9 NAILFOLD CAPILLAROSCOPY 115 84% 1% 63
10 SYSTEMIC SCLEROSIS SCLERODERMA 111 66% 1% 103

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Mechanisms of Disease: Scleroderma. 2009 346 93 60%
Systemic sclerosis: a prototypic multisystem fibrotic disorder 2007 390 110 75%
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 2015 3 37 84%
Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis 2015 3 74 76%
Scleroderma renal crisis 2015 2 50 90%
Autoantibodies in systemic sclerosis 2005 217 46 76%
Incidence and prevalence of systemic sclerosis: A systematic literature review 2008 105 34 85%
Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature 2014 12 29 59%
Raynaud's phenomenon: From molecular pathogenesis to therapy 2014 11 165 62%
Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-Results from the International Scleroderma Renal Crisis Survey 2014 6 10 100%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SCLERODERMA PROGRAM 39 61% 0.5% 41
2 RHEUMATOL A 26 41% 0.6% 49
3 SCLERODERMA 25 60% 0.3% 27
4 RHEUMATOL CLIN IMMUNOGENET 24 39% 0.6% 49
5 SERV RHUMATOL A 21 39% 0.5% 43
6 RHEUMATOL CONNECT TISSUE DIS 20 36% 0.5% 45
7 RHEUMATOL AOUC 16 49% 0.3% 24
8 REFERRAL SYST AUTOIMMUNE DIS 16 51% 0.2% 22
9 EXPT RHEUMATOL 11 17% 0.7% 58
10 DENOTHE 10 26% 0.4% 35

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000023557 VIBRATION INDUCED WHITE FINGER//HAND ARM VIBRATION SYNDROME//HAND ARM VIBRATION
2 0.0000015252 EXTRACORPOREAL PHOTOCHEMOTHERAPY//PHOTOPHERESIS//EXTRACORPOREAL PHOTOPHERESIS
3 0.0000014491 DERMATOMYOSITIS//POLYMYOSITIS//INCLUSION BODY MYOSITIS
4 0.0000013044 CONGENITAL HEART BLOCK//NEONATAL LUPUS//NEONATAL LUPUS ERYTHEMATOSUS
5 0.0000010505 IDIOPATHIC PULMONARY FIBROSIS//USUAL INTERSTITIAL PNEUMONIA//PULMONARY ALVEOLAR PROTEINOSIS
6 0.0000010408 PERIOSTIN//CONNECTIVE TISSUE GROWTH FACTOR//CCN2
7 0.0000009642 PULMONARY HYPERTENSION//PULMONARY ARTERIAL HYPERTENSION//CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
8 0.0000004846 SYSTEMIC LUPUS ERYTHEMATOSUS//LUPUS//LUPUS NEPHRITIS
9 0.0000004615 ESSENTIAL THROMBOCYTHEMIA//POLYCYTHEMIA VERA//MYELOFIBROSIS
10 0.0000004541 ANTIPHOSPHOLIPID SYNDROME//ANTIPHOSPHOLIPID ANTIBODIES//LUPUS ANTICOAGULANT